Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors

被引:82
作者
Grigoriou, Odysseas
Baka, Stavroula
Makrakis, Evangelos
Hassiakos, Dimitrios
Kapparos, George
Kouskouni, Evangelia
机构
[1] Univ Athens, Aretaieion Hosp, Dept Bacteriol & Biochem, Athens 11528, Greece
[2] Univ Athens, Dept Obstet & Gynecol 2, Aretaieion Hosp, Athens, Greece
关键词
vaginal candidiasis; vaginitis; hospital infections;
D O I
10.1016/j.ejogrb.2005.09.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to evaluate the prevalence of symptomatic vaginal candidiasis and probable predisposing factors in a university-based hospital. Study design: A total of 576 cases of clinical vaginal candidiasis were enrolled in this survey and wet mount preparations, Gram-stained smears and vaginal cultures were assessed. Possible risk factors, such as pregnancy, diabetes mellitus, contraceptive and antibiotic use were evaluated. Results: Clinical vaginal candidiasis was detected in 12.1% of the cases. Candida albicans was isolated in 80.2% of patients and non-albicans species in 19.8%. Pruritus was the most common symptom (85.9%), followed by vaginal discharge (66.1%), soreness (31.1%) and dyspareunia (5.0%). Reproductive age, pregnancy, diabetes, contraception as well as recent antibiotic use correlated positively with both C. albicans and non-albicans isolates. Soreness and dyspareunia were significantly related to non-albicans species. The overall recurrence rate was 8.5%. Recurrences correlated positively to non-albicans infections. Conclusions: C. albicans was, by far, the predominant yeast isolate. Non-albicans isolates caused significantly more frequent soreness, dyspareunia and recurrences than C. albicans. Clinical and laboratory findings, together with possible predisposing factors must be taken into consideration in order to achieve appropriate treatment. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 31 条
[1]  
Ben-Haroush A, 2004, Clin Exp Obstet Gynecol, V31, P113
[2]  
Boselli F, 2004, Minerva Ginecol, V56, P149
[3]   STRATEGY PROCESS RESEARCH - FOCUSING ON CORPORATE SELF-RENEWAL [J].
CHAKRAVARTHY, BS ;
DOZ, Y .
STRATEGIC MANAGEMENT JOURNAL, 1992, 13 :5-14
[4]  
Daniels W, 2001, Infect Dis Obstet Gynecol, V9, P65, DOI 10.1155/S1064744901000138
[5]   Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes -: art. no. 1 [J].
de Leon, EM ;
Jacober, SJ ;
Sobel, JD ;
Foxman, B .
BMC INFECTIOUS DISEASES, 2002, 2 (1)
[6]   Vaginal candidosis: epidemiological and etiological factors [J].
Ferrer, J .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 :S21-S27
[7]  
Garcia-Aviles C, 2001, Allergol Immunopathol (Madr), V29, P137
[8]   Fungal culture findings in cyclic vulvitis [J].
Handa, VL ;
Stice, CW .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (02) :301-303
[9]   Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy [J].
Hillier, SL ;
Lau, RJ .
CLINICAL INFECTIOUS DISEASES, 1997, 25 :S123-S126
[10]   ALLERGY TO COITUS [J].
JONES, WR .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1991, 31 (02) :137-141